BIO-key Continues to Expand Channel Alliance Partner Program by Exhibiting at 2021 Channel Partners Conference & Expo November 1-4
October 27 2021 - 6:58AM
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider
of Identity and Access Management (IAM) and Identity-Bound
Biometric (IBB) solutions, today announced the company will exhibit
at the 2021 Channel Partners Conference and Expo, to be held at the
Mandalay Bay, in Las Vegas from November 1-4. As the first IAM
supplier to be part of their Master Agent Referral Partner Program,
BIO-key will be available for meetings, Q&A sessions, and live
demonstrations within the Intelisys booth. Intelisys, a ScanSource
company, will be located at booth #1855.
For nearly 25 years, Channel Partners has been the leader in
bringing together and enabling the channel to build relationships,
showcase top solutions and stay up-to-date on the latest trends.
The Channel Partners Conference and Expo is focused on continuing
to help partners persevere, overcome and progress.
At the event, BIO-key welcomes the opportunity to continue to
expand their Channel Alliance Partner (CAP) Program by networking
with the global channel community to create substantial new revenue
opportunities for BIO-key and their partners. Attendees are invited
to stop by the Intelisys booth, #1855, to discuss how BIO-key and
their award-winning PortalGuard IAM platform can:
- Create a strong recurring revenue stream for their
business.
- Offer an IAM solution that beats the competition in both
features and price.
- Build profitable customer relationships.
- Help them become a trusted cybersecurity advisor.
Helping partners solve their customers’ most common
cybersecurity challenges, BIO-key’s platform, PortalGuard is
an award-winning IAM solution that 1000+ global customers already
use to reduce password-related IT support calls by up to 95%,
eliminate passwords, secure remote access, prevent phishing
attacks, and improve productivity for the IT team. PortalGuard
offers flexible options for single sign-on, self-service password
reset, and over 16 multi-factor authentication methods, and is the
only IAM platform to offer Identity-Bound Biometrics, available
on-premises or in the cloud.
"Cybersecurity is now top of mind for everyone," said Fred
Corsentino, Chief Revenue Officer, BIO-key. "We look forward to
connecting with the global channel community that this event brings
together, to discuss how adding Identity-as-a-Service (IdaaS) to
their offerings can enhance their business and create stronger
relationships with their customers as they address some of the most
pressing cyber challenges."
For more information about the Channel Partners Conference and
Expo, please visit the conference website. For more information
about BIO-key’s CAP Program and solutions, please visit BIO-key's
website.
About BIO-key International, Inc.
(www.BIO-key.com)BIO-key
has over two decades of expertise in providing authentication
technology for thousands of organizations and millions of users and
is revolutionizing authentication with biometric-centric,
multi-factor identity and access management (IAM) solutions,
including its PortalGuard IAM solution, that provides convenient
and secure access to devices, information, applications, and
high-value transactions. BIO-key's patented software and hardware
solutions, with industry-leading biometric capabilities, enable
large-scale on-premises and Identity-as-a-Service (IDaaS) solutions
as well as customized enterprise and cloud solutions.
BIO-key Safe Harbor Statement All statements
contained in this press release other than statements of historical
facts are "forward-looking statements" as defined in the Private
Securities Litigation Reform Act of 1995 (the "Act"). The words
"estimate," "project," "intends," "expects," "anticipates,"
"believes," and similar expressions are intended to identify
forward-looking statements. Such forward-looking statements are
made based on management's beliefs, as well as assumptions made by,
and information currently available to, management pursuant to the
"safe harbor" provisions of the Act. These statements are not
guarantees of future performance or events and are subject to risks
and uncertainties that may cause actual results to differ
materially from those included within or implied by such
forward-looking statements. These risks and uncertainties include,
without limitation, our history of losses and limited revenue; our
ability to raise additional capital; our ability to protect our
intellectual property; changes in business conditions; changes in
our sales strategy and product development plans; changes in the
marketplace; continued services of our executive management team;
security breaches; competition in the biometric technology
industry; market acceptance of biometric products generally and our
products under development; our ability to execute and deliver on
contracts in Africa; our ability to expand into Asia, Africa and
other foreign markets; the duration and severity of the current
coronavirus COVID-19 pandemic and its effect on our business
operations, sales cycles, personnel, and the geographic markets in
which we operate; delays in the development of products and
statements of assumption underlying any of the foregoing as well as
other factors set forth under the caption see "Risk Factors'' in
our Annual Report on Form 10-K for the year ended December 31, 2020
and other filings with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date made.
Except as required by law, the Company undertakes no obligation to
disclose any revision to these forward-looking statements whether
as a result of new information, future events, or otherwise.
Additionally, there may be other factors of which the Company is
not currently aware that may affect matters discussed in
forward-looking statements and may also cause actual results to
differ materially from those discussed. In particular, the
consequences of the coronavirus outbreak to economic conditions and
the industry in general and the financial position and operating
results of our Company, in particular, have been material, are
changing rapidly, and cannot be predicted.
Engage with BIO-key: Facebook – Corporate:
https://www.facebook.com/BIOkeyInternational/LinkedIn – Corporate:
https://www.linkedin.com/company/bio-key-internationalTwitter –
Corporate: @BIOkeyIntl Twitter – Investors: @BIO_keyIR StockTwits:
BIO_keyIR
BIO-key Media Contact: Erin Knapp Matter
Communications BIO-key@matternow.com
914-260-3158
Investor Contacts: William Jones, David Collins
Catalyst IR BKYI@catalyst-ir.com 212-924-9800
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From Apr 2024 to May 2024
BIO key (NASDAQ:BKYI)
Historical Stock Chart
From May 2023 to May 2024